NARA Discovery
NARA Subscribed Scholarly Literature Discovery
Boolean search: climate AND coral · microplastic OR nanoplastic · plastic NOT freshwater · "marine heatwave"
Advanced Search
Topic searches article titles and abstracts. Starts a new search; publisher and year refine it.
Searches article titles and abstracts.
Accepts bare DOI, doi: prefix, or a doi.org URL.
Complete publisher name. Publisher imprints are grouped under their main publisher where applicable.
Exact match by full journal title or ISSN.
–
Refine Results Clear Filters
Collection
NARA Subscribed3
Publisher
Springer Nature3
Journal
Biogerontology1
GeroScience2
Publication Year
20261
20251
20191
Miles D. Witham results 3 · Newest (Page 1/1, per page 25)
Export CSV Export RIS Export current results · up to 5,000 records
Author: Miles D. Witham ×Clear All Filters
Search Results
Muscle Ageing and Sarcopenia Study (MASS) Lifecourse: a valuable resource for understanding skeletal muscle ageingNARA Subscribed
GeroScience · 2026 · Springer
Rachel Cooper; Christopher Hurst; Holly Syddall; Helen Atkinson; Jonathan G. Bunn; Daniela Carpinelli; Antoneta Granic; Susan J. Hillman; Emma Grace Lewis; Claire McDonald; Katie Sloan; Karen Suetterlin; Miles D. Witham; Avan A. Sayer
View Details View Full Text
Effect of acipimox on skeletal muscle biochemistry, structure and function in older people with probable sarcopenia: an experimental medicine studyNARA Subscribed
GeroScience · 2025 · Vol. 47 · Issue 4 · Springer
Claire McDonald; Craig Alderson; Matthew G. Birkbeck; Silvia Del Din; Gráinne S. Gorman; Kieren G. Hollingsworth; Cameron Kirk; Clare Massarella; Lynn Rochester; Helen A. L. Tuppen; Charlotte Warren; Avan A. Sayer; Miles D. Witham
Background Skeletal muscle nicotinamide adenine dinucleotide (NAD) concentrations are low in people with sarcopenia. Increasing NAD concentrations may offer a novel therapy. This study tested if acipimox (a NAD precursor) improves skeletal muscle NAD concentration and function in people with probable sarcopenia. Participants aged 65 and over with low walk speed (< 0.8 m/s) and low muscle strength (by 2019 European Working Grou...
View Details View Full Text
Bridging the gap between the laboratory and the clinic for patients with sarcopeniaNARA Subscribed
Biogerontology · 2019 · Vol. 20 · Issue 2 · Springer
Miles D. Witham
View Details View Full Text